Pantoprazole-d4
Pantoprazole-d4 (BY1023-d4) is deuterium labeled Pantoprazole. Pantoprazole (BY10232) is an orally active and potent proton pump inhibitor (PPI). Pantoprazole, a substituted benzimidazole, is a potent H+/K+-ATPase inhibitor with an IC50 of 6.8 μM. Pantoprazole improves pH stability and has anti-secretory, anti-ulcer activities. Pantoprazole significantly increased tumor growth delay combined with Doxorubicin[4].
Product Specifications
CAS Number
934294-71-0
Product Name Alternative
BY1023-d4; SKF96022-d4
UNSPSC
12352005
Target
Isotope-Labeled Compounds
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Smiles
COC(C(OC)=C([2H])C([2H])=N1)=C1C([2H])([2H])S(C2=NC3=CC(OC(F)F)=CC=C3N2)=O
Molecular Formula
C16H11D4F2N3O4S
Molecular Weight
387.39
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
P21WAF1 (Tumor Suppressor Protein) (AC8), CF640R conjugate, 0.1mg/mL
